« First Artist (FAN.L) - trading update
FirstGrowth Capital (FGC.V) - technology is changing the economics of seismic services »

CeNeS Pharmaceuticals (CEN.L) - M6G hits the target profile

M6G hits the target profile but development work still outstanding will delay the European launch and is likely to bring in partnering. …


From Research Connect – Latest Financial Reports

This entry was posted on Thursday, February 22nd, 2007 at 9:21 pm and is filed under Penny Stock Trading. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.